EX-23.1 3 plx-20231231xex23d1.htm EX-23.1

​ | ​
​ | Exhibit 23.1

​

​

CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM

We hereby consent to the incorporation by reference in the Registration Statements on Form S-3 (No. 333-237736 and No. 333-264394) and on Form S-8 (No. 333-148983, No. 333-182677, No. 333-203960, No. 333-225526, No. 333-239101, No. 333-266131 and No. 333-273396) of Protalix BioTherapeutics, Inc. of our report dated March 14, 2024 relating to the financial statements, which appears in this Form 10-K.

​

​

​

​

X, 2022 ​ | ​ ​ ​ ​ ​
Tel-Aviv, Israel March 14, 2024 | /s/ Kesselman & Kesselman Certified Public Accountants (lsr.) A member firm of PricewaterhouseCoopers International Limited ​
​ | ​

​